Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
Palma DA, Olson R, Harrow S, Correa RJM, Schneiders F, Haasbeek CJA, Rodrigues GB, Lock M, Yaremko BP, Bauman GS, Ahmad B, Schellenberg D, Liu M, Gaede S, Laba J, Mulroy L, Senthi S, Louie AV, Swaminath A, Chalmers A, Warner A, Slotman BJ, de Gruijl TD, Allan A, Senan S.
Palma DA, et al. Among authors: swaminath a.
BMC Cancer. 2019 Aug 19;19(1):816. doi: 10.1186/s12885-019-5977-6.
BMC Cancer. 2019.
PMID: 31426760
Free PMC article.
Clinical Trial.